|
Items in cart [4] |
Questions? Call 888-624-8373 |
| Copyright © 2009. National Academy of Sciences. All rights reserved. Terms of Use and Privacy Statement |
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 199
Appendix D
Cardiovascular and Peripheral
Vascular Cover Sheet
This is one of 32 cover sheets addressing the research areas represented
by the nominated topics provided to the committee to guide their prioriti-
zation process. The data included the committee’s condition-level criteria
pertinent to the specific research area.
(n) the number in parenthesis signifies the number of conditions on the
particular list
x signifies condition appears on the list of the top (n) conditions
blank signifies that condition does not appear on the list of the top (n)
conditions
Prevalence—Number of people receiving care for selected conditions,
2006
MEPS Survey Data
All age groups Age 0-1 years Ages 1-17
Condition (20) (5) years (11) 65+ years (8)
Hypertension X X
Hyperlipidemia X X
Heart conditions X X
Mortality—Number of deaths, 2005
National and Vital Statistics Report
All age Age 0-1 Ages 1-14 65+ years
Condition groups (20) years (8) years (6) (20)
Ischemic heart
X X
diseases
Acute myocardial
X X
Infarction
OCR for page 200
00 INITIAL NATIONAL PRIORITIES FOR CER
All age Age 0-1 Ages 1-14 65+ years
Condition groups (20) years (8) years (6) (20)
Cerebrovascular
X X
diseases
Heart failure X X
Hypertensive heart
X X
disease
Major
cardiovascular X
diseases
Diseases of heart X
Morbidity—Number of events for selected conditions including: Hospital
outpatient or office based, Hospital inpatient, ER, Home health visits,
and Prescribed medicines, 2006
MEPS Survey Data
Condition All age groups (12) Ages 0-17 years (12)
Hypertension X
Heart conditions X
Cost—Total expenses for selected conditions including: Hospital out-
patient or office based, Hospital inpatient, ER, Home health visits, and
Prescribed medicines, 2006
MEPS Survey Data
All ages Age 0-1 years Age 1-17 years Age 65+ years
Condition (10) (10) (10) (10)
Heart conditions X X
Hypertension X X
OCR for page 201
0
APPENDIX D
variability—The Dartmouth Institute for Health Policy and Clinical Prac-
tice Data, 2005
variation of hospitalization for variation in treatment for
Condition procedure (11) conditions (11)
Congestive heart X
failure
Cardiac arrhythmia X
Stroke X
PCI X
Lower extremity X
bypass
Carotid X
endarterectomy
CABG X
Condition Appears on Other Priority Lists
AHRQ Effective National
Health Care Healthy People Quality Cochrane
Condition program (19) 2010 (32) Forum (5) (15)
x x
Cardiovascular disease, X
including stroke and
hypertension
Funding Gap—Number of Trials by Sponsor Type, February 2000 to
April 2009
Clinicaltrials.gov
Other
Federal universities/
Condition NIH Industry Agencies Organizations Total
Anticoagulant therapy 6 43 1 37 74
for myocardial
infarction
Anticoagulant therapy 9 43 0 44 81
for stroke
Cardiac imaging 107 154 3 287 537
OCR for page 202
0 INITIAL NATIONAL PRIORITIES FOR CER
Other
Federal universities/
Condition NIH Industry Agencies Organizations Total
Congestive heart 87 227 35 268 537
failure
Hyperlipidemia 103 365 22 257 666
Hypertension 535 1080 74 1211 2616
Stable angina pectoris 93 151 6 262 439
or acute coronary
syndrome
REFERENCES
AHRQ (Agency for Healthcare Research and Quality). 2009. Medical Expenditure Panel
Survey. http://www.meps.ahrq.gov/mepsweb/ (accessed March 10, 2009).
Doyle, J., E. Waters, D. Yach, D. McQueen, A. De Francisco, T. Stewart, P. Reddy, A. M. Gul-
mezoglu, G. Galea, and A. Portela. 2005. Global priority setting for Cochrane systematic
reviews of health promotion and public health research. Journal of Epidemiology and
Community Health 59:193-197.
HHS (Department of Health and Human Services). 2000. Healthy People 2010: Understand-
ing and improving health. Place Published: U.S. Government Printing Office. http://purl.
access.gpo.gov/GPO/LPS4217 (accessed April 3, 2009).
Kung, H.-C., D. L. Hoyert, J. Xu, S. L. Murphy, and Division of Vital Statistics. 2008.
Deaths: Final data for 00. National Vital Statistics Reports National Center for Health
Statistics.
NIH (National Institutes of Health). 2009. Clinicaltrials.Gov. http://www.clinicaltrials.gov/
(accessed June 5, 2009).
NPP (National Priorities Partnership). 2008. National priorities and goals. Washington, DC:
National Quality Forum.
Wennberg, J. E. 2009 (unpublished). Recommendations to the Institute of Medicine on com-
parative effectiveness research priorities. Submitted in response to a request from the
Institute of Medicine Committee on Comparative Effectiveness Research Prioritization.
The Dartmouth Institute for Health Policy and Clinical Practice.
Whitlock, E. P., S. A. Lopez, S. Chang, M. Helfand, M. Eder, and N. Floyd. 2009. Identifying,
selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ
and the Effective Health Care Program. http://effectivehealthcare.ahrq.gov/repFiles/
20090427IdenttifyingTopics.pdf (accessed June 5, 2009).
